Fecal microbiota transplantation: In perspective

Therapeutic Advances in Gastroenterology

Volumn 9, Issue 2, 2016, Pages 229-239

  Gupta, Shaan ^a   Allen Vercoe, Emma ^b   Petrof, Elaine O ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

bacteriotherapy; Clostridium difficile infection; fecal microbiota transplantation; gut microbiome; inflammatory bowel disease

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ENEMA; FIDAXOMICIN; METRONIDAZOLE; RIFAXIMIN; VANCOMYCIN;

ABDOMINAL TENDERNESS; BLOATING; CHILL; CLOSTRIDIUM DIFFICILE INFECTION; COLONOSCOPY; CONSTIPATION; CROHN DISEASE; DIABETES MELLITUS; DIARRHEA; DIGESTIVE TUBE; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERABILITY; DYSBIOSIS; DYSLIPIDEMIA; ESOPHAGOGASTRODUODENOSCOPY; FECAL MICROBIOTA TRANSPLANTATION; FECES ANALYSIS; FEVER; FLATULENCE; HEART DISEASE; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INTESTINE FLORA; IRRITABLE COLON; META ANALYSIS (TOPIC); METABOLOMICS; METAGENOMICS; MICROBIAL COMMUNITY; NASOGASTRIC TUBE; NASOJEJUNAL TUBE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PARTICULATE MATTER; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REMISSION; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW (TOPIC); ULCERATIVE COLITIS; VOMITING;

EID: 84957886668     PISSN: 1756283X     EISSN: 17562848     Source Type: Journal    
DOI: 10.1177/1756283X15607414     Document Type: Review

References (101)

1. Alang N., Kelly C., (2015) Weight gain after fecal microbiota transplantation. Open Forum Infect Dis 2. DOI: 10.1093/ofid/ofv004.
2. Andrews P., Borody T., Shortis N., (1995) Bacteriotherapy for chronic constipation-long term follow up. Gastroenterology 108: A563.
3. Angelberger S., Reinisch W., Makristathis A., Lichtenberger C., Dejaco C., Papay P., et al. (2013) Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol 108: 1620-1630.
4. Bakken J., Borody T., Brandt L., Brill J., Demarco D., Franzos M., et al. (2011) Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 9: 1044-1049.
5. Bartlett J., Gerding D., (2008) Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 46 (Suppl. 1): S12-S18.
6. Bauer M., Notermans D., Van Benthem B., Brazier J., Wilcox M., Rupnik M., et al. (2011) Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377: 63-73.
7. Borody T., Khoruts A., (2012) Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol 9: 88-96.
8. Brandt L., Aroniadis O., Mellow M., Kanatzar A., Kelly C., Park T., et al. (2012) Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol 107: 1079-1087.
9. Buie T., (2015) Potential etiologic factors of microbiome disruption in autism. Clin Ther 37: 976-983.
10. Cammarota G., Ianiro G., Gasbarrini A., (2014) Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol 48: 693-702.
11. Casellas F., Borruel N., Papo M., Guarner F., Antolín M., Videla S., et al. (1998) Antiinflammatory effects of enterically coated amoxicillin-clavulanic acid in active ulcerative colitis. Inflamm Bowel Dis 4: 1-5.
12. Cho I., Blaser M., (2012) The human microbiome: at the interface of health and disease. Nat Rev Genet 13: 260-270.
13. Cho I., Yamanishi S., Cox L., Methé B., Zavadil J., Li K., et al. (2012) Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488: 621-626.
14. Claesson M., Jeffery I., Conde S., Power S., O'Connor E., Cusack S., et al. (2012) Gut microbiota composition correlates with diet and health in the elderly. Nature 488: 178-184.
15. Claud E., Keegan K., Brulc J., Lu L., Bartels D., Glass E., et al. (2013) Bacterial community structure and functional contributions to emergence of health or necrotizing enterocolitis in preterm infants. Microbiome 1: 20.
16. Colman R., Rubin D., (2014) Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis 8: 1569-1581.
17. Couturier-Maillard A., Secher T., Rehman A., Normand S., De Arcangelis A., Haesler R., et al. (2013) NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J Clin Invest 123: 700-711.
18. Damman C., Miller S., Surawicz C., Zisman T., (2012) The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation? Am J Gastroenterol 107: 1452-1459.
19. David L., Maurice C., Carmody R., Gootenberg D., Button J., Wolfe B., et al. (2014) Diet rapidly and reproducibly alters the human gut microbiome. Nature 505: 559-563.
20. De Filippo C., Cavalieri D., Di Paola M., Ramazzotti M., Poullet J., Massart S., et al. (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and Rural Africa. Proc Natl Acad Sci U S A 107: 14691-14696.
21. De Leon L., Watson J., Kelly C., (2013) Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol 11: 1036-1038.
22. Dethlefsen L., Relman D., (2011) Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 108 (Suppl. 1): 4554-4561.
23. Dicksved J., Lindberg M., Rosenquist M., Enroth H., Jansson J., Engstrand L., (2009) Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. J Med Microbiol 58: 509-516.
24. Doerner K., Takamine F., Lavoie C., Mallonee D., Hylemon P., (1997) Assessment of fecal bacteria with bile acid 7 alpha-dehydroxylating activity for the presence of bai-like genes. Appl Environ Microbiol 63: 1185-1188.
25. Dubberke E., Olsen M., (2012) Burden of Clostridium difficile on the healthcare system. Clin Infect Dis 55 (Suppl. 2): S88-S92.
26. Eckburg P., Bik E., Bernstein C., Purdom E., Dethlefsen L., Sargent M., et al. (2005) Diversity of the human intestinal microbial flora. Science 308: 1635-1638.
27. Eiseman B., Silen W., Bascom G., Kauvar A., (1958) Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 44: 854-859.
28. Erickson A., Cantarel B., Lamendella R., Darzi Y., Mongodin E., Pan C., et al. (2012) Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's disease. PLoS One 7: e49138.
29. FDA. (2014) Draft Guidance for Industry: Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies. Silver Spring, MD: US Food and Drug Administration.
30. Frank D., Robertson C., Hamm C., Kpadeh Z., Zhang T., Chen H., et al. (2011) Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 17: 179-184.
31. Frank D., St Amand A., Feldman R., Boedeker E., Harpaz N., Pace N., (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104: 13780-13785.
32. Gill S., Pop M., Deboy R., Eckburg P., Turnbaugh P., Samuel B., et al. (2006) Metagenomic analysis of the human distal gut microbiome. Science 312: 1355-1359.
33. Gough E., Shaikh H., Manges A., (2011) Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 53: 994-1002.
34. Hamilton M., Weingarden A., Sadowsky M., Khoruts A., (2012) Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 107: 761-767.
35. Hamilton M., Weingarden A., Unno T., Khoruts A., Sadowsky M., (2013) High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria. Gut Microbes 4: 125-135.
36. Harrell L., Wang Y., Antonopoulos D., Young V., Lichtenstein L., Huang Y., et al. (2012) Standard colonic lavage alters the natural state of mucosal-associated microbiota in the human colon. PLoS One 7: e32545.
37. Health Canada. (2015) Guidance Document: Fecal Microbiota Therapy Used in the Treatment of Clostridium difficile Infections. Ottawa, ON: Health Canada.
38. Hirano S., Nakama R., Tamaki M., Masuda N., Oda H., (1981) Isolation and characterization of thirteen intestinal microorganisms capable of 7 alpha-dehydroxylating bile acids. Appl Environ Microbiol 41: 737-745.
39. Hoffman E., Vonwald T., Hansen K., (2015) The metabolic syndrome. S D Med Spec. No.: 24-28.
40. Hollister E., Gao C., Versalovic J., (2014) Compositional and functional features of the gastrointestinal microbiome and their effects on human health. Gastroenterology 146: 1449-1458.
41. Jalanka-Tuovinen J., Salonen A., Nikkilä J., Immonen O., Kekkonen R., Lahti L., et al. (2011) Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms. PLoS One 6: e23035.
42. Kassam Z., Lee C., Yuan Y., Hunt R., (2013) Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 108: 500-508.
43. Kelly C., Ihunnah C., Fischer M., Khoruts A., Surawicz C., Afzali A., et al. (2014) Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol 109: 1065-1071.
44. Kelly C., Kahn S., Kashyap P., Laine L., Rubin D., Atreja A., et al. (2015) Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook. Gastroenterology 149: 223-227.
45. Kelly C., Lamont J., (2008) Clostridium difficile-more difficult than ever. N Engl J Med 359: 1932-1940.
46. Khan K., Ullman T., Ford A., Abreu M., Abadir A., Marshall J., et al. (2011) Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol 106: 661-673.
47. Khoruts A., Dicksved J., Jansson J., Sadowsky M., (2010) Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile -associated diarrhea. J Clin Gastroenterol 44: 354-360.
48. Kitahara M., Takamine F., Imamura T., Benno Y., (2000) Assignment of Eubacterium sp. vpi 12708 and related strains with high bile acid 7alpha-dehydroxylating activity to Clostridium scindens and proposal of Clostridium hylemonae sp. nov., isolated from human faeces. Int J Syst Evol Microbiol 50: 971-978.
49. Koloski N., Talley N., Boyce P., (2002) Epidemiology and health care seeking in the functional GI disorders: a population-based study. Am J Gastroenterol 97: 2290-2299.
50. Le Chatelier E., Nielsen T., Qin J., Prifti E., Hildebrand F., Falony G., et al. (2013) Richness of human gut microbiome correlates with metabolic markers. Nature 500: 541-546.
51. Ley R., Turnbaugh P., Klein S., Gordon J., (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444: 1022-1023.
52. Liou A., Paziuk M., Luevano J., Machineni S., Turnbaugh P., Kaplan L., (2013) Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med 5: 178ra141.
53. Llopis M., Cassard-Doulcier A., Boschat L., Bruneau A., Cailleux F., Rabot S., et al. (2014) Intestinal dysbiosis explains inter-individual differences in susceptibility to alcoholic liver disease. Abstract presented at the International Liver Congress. J Hepatol 60 (Suppl.): S1-S598.
54. Loftus E., (2004) Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 126: 1504-1517.
55. Louie T., Miller M., Mullane K., Weiss K., Lentnek A., Golan Y., et al. (2011) Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 364: 422-431.
56. Miller B., Chen L., Sexton D., Anderson D., (2011) Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol 32: 387-390.
57. Mills K., (2011) TLR-dependent T cell activation in autoimmunity. Nat Rev Immunol 11: 807-822.
58. Moayyedi P., Surette M., Kim P., Libertucci J., Wolfe M., Onischi C., et al. (2015) Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized, controlled trial. Gastroenterology 149: 102-109.
59. Morgan X., Tickle T., Sokol H., Gevers D., Devaney K., Ward D., et al. (2012) Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 13: R79.
60. Natividad J., Pinto-Sanchez M., Galipeau H., Jury J., Jordana M., Reinisch W., et al. (2015) Ecobiotherapy rich in firmicutes decreases susceptibility to colitis in a humanized gnotobiotic mouse model. Inflamm Bowel Dis 21: 1883-1893.
61. Nava G., Friedrichsen H., Stappenbeck T., (2011) Spatial organization of intestinal microbiota in the mouse ascending colon. ISME J 5: 627-638.
62. Ng K., Ferreyra J., Higginbottom S., Lynch J., Kashyap P., Gopinath S., et al. (2013) Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502: 96-99.
63. Ott S., Musfeldt M., Wenderoth D., Hampe J., Brant O., Fölsch U., et al. (2004) Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 53: 685-693.
64. Petrof E., Gloor G., Vanner S., Weese S., Carter D., Daigneault M., et al. (2013) Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'repopulating' the gut. Microbiome 1: 3.
65. Pinn D., Aroniadis O., Brandt L., (2013) Follow-up study of fecal microbiota transplantation (FMT) for the treatment of refractory irritable bowel syndrome (IBS). Presented at the American College of Gastroenterology Annual Meeting; San Diego, CA, abstract 2013: P1688.
66. Pinn D., Aroniadis O., Brandt L., (2015) Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)? Neurogastroenterol Motil 27: 19-29.
67. Qin J., Li R., Raes J., Arumugam M., Burgdorf K., Manichanh C., et al. (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59-65.
68. Quera R., Espinoza R., Estay C., Rivera D., (2014) Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection. J Crohns Colitis 8: 252-253.
69. Rea M., Sit C., Clayton E., O'Connor P., Whittal R., Zheng J., et al. (2010) Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proc Natl Acad Sci U S A 107: 9352-9357.
70. Ridaura V., Faith J., Rey F., Cheng J., Duncan A., Kau A., et al. (2013) Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341: 1241214.
71. Ridlon J., Kang D., Hylemon P., (2006) Bile salt biotransformations by human intestinal bacteria. J Lipid Res 47: 241-259.
72. Rossen N., Fuentes S., Van Der Spek M., Tijssen J., Hartman J., Duflou A., et al. (2015) Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology 149: 110-118.
73. Rossen N., Macdonald J., De Vries E., D'Haens G., De Vos W., Zoetendal E., et al. (2015) Fecal microbiota transplantation as novel therapy in gastroenterology: a systematic review. World J Gastroenterol 21: 5359-5371.
74. Sartor R., (2008) Microbial influences in inflammatory bowel diseases. Gastroenterology 134: 577-594.
75. Sartor R., (2004) Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126: 1620-1633.
76. Schwartz M., Gluck M., Koon S., (2013) Norovirus gastroenteritis after fecal microbiota transplantation for treatment of Clostridium difficile infection despite asymptomatic donors and lack of sick contacts. Am J Gastroenterol 108: 1367.
77. Shahinas D., Silverman M., Sittler T., Chiu C., Kim P., Allen-Vercoe E., et al. (2012) Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16s RRNA gene deep sequencing. MBio 3: e00338-12.
78. Smits L., Bouter K., De Vos W., Borody T., Nieuwdorp M., (2013) Therapeutic potential of fecal microbiota transplantation. Gastroenterology 145: 946-953.
79. Sokol H., Pigneur B., Watterlot L., Lakhdari O., Bermúdez-Humarán L., Gratadoux J., et al. (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105: 16731-16736.
80. Sokol H., Seksik P., Furet J., Firmesse O., Nion-Larmurier I., Beaugerie L., et al. (2009) Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15: 1183-1189.
81. Sorg J., Sonenshein A., (2008) Bile salts and glycine as cogerminants for Clostridium difficile spores. J Bacteriol 190: 2505-2512.
82. Stellwag E., Hylemon P., (1978) Characterization of 7-alpha-dehydroxylase in Clostridium leptum. Am J Clin Nutr 31: S243-S247.
83. Surawicz C., Brandt L., Binion D., Ananthakrishnan A., Curry S., Gilligan P., et al. (2013) Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 108: 478-498.
84. Suskind D., Brittnacher M., Wahbeh G., Shaffer M., Hayden H., Qin X., et al. (2015) Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease. Inflamm Bowel Dis 21: 556-563.
85. Takamine F., Imamura T., (1995) Isolation and characterization of bile acid 7-dehydroxylating bacteria from human feces. Microbiol Immunol 39: 11-18.
86. Tap J., Mondot S., Levenez F., Pelletier E., Caron C., Furet J., et al. (2009) Towards the human intestinal microbiota phylogenetic core. Environ Microbiol 11: 2574-2584.
87. Tremaroli V., Bäckhed F., (2012) Functional interactions between the gut microbiota and host metabolism. Nature 489: 242-249.
88. Turnbaugh P., Ley R., Mahowald M., Magrini V., Mardis E., Gordon J., (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.
89. Van Nood E., Speelman P., Nieuwdorp M., Keller J., (2014) Fecal microbiota transplantation: facts and controversies. Curr Opin Gastroenterol 30: 34-39.
90. Van Nood E., Vrieze A., Nieuwdorp M., Fuentes S., Zoetendal E., De Vos W., et al. (2013) Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 368: 407-415.
91. Varela E., Manichanh C., Gallart M., Torrejón A., Borruel N., Casellas F., et al. (2013) Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis. Aliment Pharmacol Ther 38: 151-161.
92. Vermeire S., Joossens M., Verbeke K., Hildebrand F., Machiels K., Van Den Broeck K., et al. (2012) Sa1922 pilot study on the safety and efficacy of faecal microbiota transplantation in refractory Crohn's disease. Gastroenterology 142: S360.
93. Vrieze A., Van Nood E., Holleman F., Salojärvi J., Kootte R., Bartelsman J., et al. (2012) Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143: 913-916.
94. Wang Y., Hoenig J., Malin K., Qamar S., Petrof E., Sun J., et al. (2009) 16s rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J 3: 944-954.
95. Weingarden A., Chen C., Bobr A., Yao D., Lu Y., Nelson V., et al. (2014) Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am J Physiol Gastrointest Liver Physiol 306: G310-G319.
96. Willing B., Halfvarson J., Dicksved J., Rosenquist M., Järnerot G., Engstrand L., et al. (2009) Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis 15: 653-660.
97. Yang L., Lu X., Nossa C., Francois F., Peek R., Pei Z., (2009) Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology 137: 588-597.
98. Yao X., Yang Y., Cui L., Zhao K., Zhang Z., Peng L., et al. (2012) Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study. J Gastroenterol Hepatol 27: 760-765.
99. Youngster I., Russell G., Pindar C., Ziv-Baran T., Sauk J., Hohmann E., (2014) Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA 312: 1772-1778.
100. Zhang Y., Li Y., (2014) Inflammatory bowel disease: pathogenesis. World J Gastroenterol 20: 91-99.
101. Zhang F., Luo W., Shi Y., Fan Z., Ji G., (2012) Should we standardize the 1,700-year-old fecal microbiota transplantation? Am J Gastroenterol 107: 1755-1756.